France Bed Holdings Co Ltd
TSE:7840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (4), the stock would be worth ¥1 221.07 (5% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.2 | ¥1 292 |
0%
|
| 3-Year Average | 4 | ¥1 221.07 |
-5%
|
| 5-Year Average | 3.6 | ¥1 112.68 |
-14%
|
| Industry Average | 8.3 | ¥2 532.91 |
+96%
|
| Country Average | 8.7 | ¥2 650.12 |
+105%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
France Bed Holdings Co Ltd
TSE:7840
|
43.1B JPY | 4.2 | 15.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
100.2B USD | 14.3 | 56.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.5B EUR | 7.7 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.9B EUR | 9.3 | 18.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 9.1 | 23.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.9B USD | 12 | 22.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 11.9 | 24.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 5.3 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | -30.2 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 7.3 | 14.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
France Bed Holdings Co Ltd
Glance View
FRANCE BED HOLDINGS CO., LTD. operates as a holding company which provides management strategy for the FRANCE BED Group and audits the business activities of all group companies. The company is headquartered in Shinjuku, Tokyo-To and currently employs 1,631 full-time employees. The company went IPO on 2004-03-30. The firm operates through two business segments. The Medical Service segment is engaged in manufacturing, purchase, leasing, retail and wholesale of nursing beds and welfare equipment, as well as linen supply for hospitals and hotels. The Interior Healthy segment is engaged in manufacturing, purchase and wholesale of bed, furniture, bedroom product and healthcare equipment, as well as the door-to-door selling, advertising and exhibition operation. The firm is also involved in the real estate leasing business.
